Race differences in iliofemoral vein stenting for chronic venous insufficiency

Abstract

Introduction

Major disparities in outcomes by race are present throughout vascular surgery, yet little has been published on iliac vein stent outcomes by race. This retrospective study assessed iliac vein stent outcomes by patient race.

Methods

Patients who underwent iliac vein stenting at a single institution for chronic venous insufficiency (CVI) from 2011 to 2021 were reviewed. Demographic, preoperative, perioperative, and postoperative data were collected. Self-reported race groups included Asian, Black, Hispanic, and White. Univariate differences were analyzed using χ² tests for categorical variables and 1-way ANOVA for continuous variables. Outcomes included change in Venous Clinical Severity Score (VCSS) at interval timepoints relative to a preoperative baseline and reinterventions. Logistic regression models were used to determine the unadjusted and adjusted odds ratio (OR) of any minor and major reintervention. Multivariate regression models controlled for demographic and comorbidity characteristics.

Results

A total of 827 patients were included. Asian patients were younger and had a greater proportion of male patients, lower Body mass index (BMI), less smoking history, and fewer comorbidities. White patients were more likely to have a history of deep vein thrombosis (DVT). White patients presented with the most severe CVI symptoms as defined by both Clinical-Etiological-Anatomical-Pathophysiological (CEAP) classification and preoperative VCSS composite scores. There were no differences in acute DVT, number of stents deployed, and bilateral versus unilateral stent placement. Black patients had the longest average days of follow-up, followed sequentially by Hispanic, White, and Asian. Black patients had the most reinterventions, while Asian patients had the fewest. Asian patients were less likely to have a major reintervention. No differences in VCSS composite or change in VCSS were observed.

Conclusions

In patients with CVI, Asian patients presented younger and healthier, while White patients presented with the most severe symptoms. No differences were observed in VCSS outcomes, though Black patients had the most reinterventions.

Keywords

Chronic venous insufficiency iliofemoral vein stenting disparities

Get full access to this article

View all access options for this article.

References

Radaideh

Patel

Shammas

. Iliac vein compression: epidemiology, diagnosis and treatment. Vasc Health Risk Manag 2019; 15: 115–122. DOI: 10.2147/vhrm.S203349.

Mousa

AbuRahma

. May-thurner syndrome: update and review. Ann Vasc Surg 2013; 27: 984–995. DOI: 10.1016/j.avsg.2013.05.001.

Kahn

. The post-thrombotic syndrome. Hematol Am Soc Hematol Educ Program 2016; 2016: 413–418. DOI: 10.1182/asheducation-2016.1.413.

Rowe

Weaver

Lane

, et al. Racial and ethnic differences in patterns of treatment for acute peripheral arterial disease in the United States, 1998-2006. J Vasc Surg 2010; 51: 21s–26s. DOI: 10.1016/j.jvs.2009.09.066.

Huber

Wang

Wheeler

, et al. Impact of race on the treatment for peripheral arterial occlusive disease. J Vasc Surg 1999; 30: 417–425. DOI: 10.1016/s0741-5214(99)70068-6.

Allison

Denenberg

, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med 2007; 32: 328–333. DOI: 10.1016/j.amepre.2006.12.010.

Lemaire

Cook

Tackett

, et al. The impact of race and insurance type on the outcome of endovascular abdominal aortic aneurysm (AAA) repair. J Vasc Surg 2008; 47: 1172–1180. DOI: 10.1016/j.jvs.2008.01.033.

Trivedi

Lind

Ray

, et al. Race and sex disparities in outcomes of dialysis access maintenance interventions. J Vasc Interv Radiol 2018; 29: 476–481. DOI: 10.1016/j.jvir.2017.10.018.

Gurbel

Bliden

Cohen

, et al. Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting. Blood Coagul Fibrinolysis 2008; 19: 268–275. DOI: 10.1097/MBC.0b013e3282ff76ae.

10.

Zaghloul

Abdul-Malak

Cherfan

, et al. Female gender is a predictor of lower iliac vein stenting patency rates. Ann Vasc Surg 2022; 78: 247–256. DOI: 10.1016/j.avsg.2021.06.027.

11.

Alsheekh

Hingorani

Aurshina

, et al. Demographic and clinical features do not affect the outcome of combined endovenous therapy to treat leg swelling. Vascular 2018; 26: 472–476. DOI: 10.1177/1708538118760742.

12.

Alsheekh

Hingorani

Ferm

, et al.

Is there an effect of race/ethnicity on early complications of iliac vein stenting?

Vascular 2017; 25: 549–552. DOI: 10.1177/1708538117699335.

13.

El Mekabaty

Obuchowski

Luciano

, et al. Predictors for venous sinus stent retreatment in patients with idiopathic intracranial hypertension. J Neurointerv Surg 2017; 9: 1228–1232. DOI: 10.1136/neurintsurg-2016-012803.

14.

Lurie

Chen

Chait

, et al. Iliac vein stenting for chronic proximal venous outflow obstruction in a predominantly Asian-American cohort. Ann Vasc Surg 2020; 66: 356–361. DOI: 10.1016/j.avsg.2020.01.018.

15.

Passman

McLafferty

Lentz

, et al. Validation of venous clinical severity score (vcss) with other venous severity assessment tools from the American venous forum, national venous screening program. J Vasc Surg 2011; 54: 2s–9s. DOI: 10.1016/j.jvs.2011.05.117.